Subscribe to receive investor news and updates.

Thanks for subscribing. You will now receive the latest investor news and updates from VivoPower.

Oops! Something went wrong while submitting the form.

Link Four Link Five Link Six

Our Businesses Investors

Company B Corp Core Values

Our People Contact

NASDAQ

VVPR

$2.75

5.50%

VivoPower secures Mpox diagnostic tests distribution heads of agreement for Singapore, Hong Kong and Australia with Sansure Biotech Inc

September 16, 2024

Suite 4, 7th Floor
50 Broadway
London, UK
SW1H 0DB

Quick Links

AI Data Centers Investors Resources About Us Our People Contact Us

Social

LinkedIn YouTube X Stocktwits Facebook Instagram